A Phase II, Double-Blind, Randomized, Placebo-Controlled Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2018
At a glance
- Drugs SK 1405 (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors Sanwa Kagaku Kenkyusho
- 12 Nov 2018 Status changed from active, no longer recruiting to completed.
- 14 Sep 2018 Planned End Date changed from 1 Aug 2018 to 1 Dec 2018.
- 14 Sep 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Dec 2018.